Nanopx Biosciences
Organisation
People
Sources: reporter.nih.gov
Grants and prizes
Brain-targeted antibody for Alzheimer's disease therapy, R41AG102139, US$483.5k, 17 Sept 2026
Sources: reporter.nih.gov
Named in competing interests
Reverse the progression of Alzheimer's disease through Nano-ERASER-based adult neuroregeneration
Founder, Board or leadership role, 26 Aug 2026
Sources: pubmed.ncbi.nlm.nih.gov